Lazard Asset Management
LUMO

Lazard Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Lazard Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-741
Closed -$265K – 1216
2014
Q4 		$265K Buy
+741
New +$221K ﹤0.01% 883

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Lazard Asset Management's LUMO Position: Q1 2015 in Review

Lazard Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2015, closing a stake of 741 shares — an estimated $265K sold.

Lazard Asset Management first reported a position in LUMO in Q4 2014 and held it in 1 quarter. The position peaked at $265K in Q4 2014. 124 funds tracked by Wall St. Rank hold LUMO as of Q1 2015.

  • Lazard Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Lazard Asset Management sold 741 Lumos Pharma, Inc. Common Stock shares in Q1 2015, an estimated $265K.
  • Lazard Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Lazard Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $265K in Q4 2014.
  • 124 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2015.

Based on Lazard Asset Management's 13F filing for Q1 2015, filed 15 May 2015.